248 related articles for article (PubMed ID: 25836609)
1. Incidence and clinical characteristics of pulmonary hypertension in patients with idiopathic pulmonary fibrosis.
Yan W; Peng LY; Ban CJ; Xu XF; Zhu M; Liu Y; Zhang S; Zhai ZG; Wang C; Dai HP
Chin Med J (Engl); 2015 Apr; 128(7):896-901. PubMed ID: 25836609
[TBL] [Abstract][Full Text] [Related]
2. Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension.
Boutou AK; Pitsiou GG; Trigonis I; Papakosta D; Kontou PK; Chavouzis N; Nakou C; Argyropoulou P; Wasserman K; Stanopoulos I
Respirology; 2011 Apr; 16(3):451-8. PubMed ID: 21122030
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.
Castria D; Refini RM; Bargagli E; Mezzasalma F; Pierli C; Rottoli P
Int J Immunopathol Pharmacol; 2012; 25(3):681-9. PubMed ID: 23058018
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters.
Papakosta D; Pitsiou G; Daniil Z; Dimadi M; Stagaki E; Rapti A; Antoniou K; Tzouvelekis A; Kontakiotis T; Tryfon S; Polychronopoulos V; Bouros D
Lung; 2011 Oct; 189(5):391-9. PubMed ID: 21660584
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in chronic lung diseases.
Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis.
Nadrous HF; Pellikka PA; Krowka MJ; Swanson KL; Chaowalit N; Decker PA; Ryu JH
Chest; 2005 Oct; 128(4):2393-9. PubMed ID: 16236900
[TBL] [Abstract][Full Text] [Related]
7. Effects of oxygen on exercise-induced increase of pulmonary arterial pressure in idiopathic pulmonary fibrosis.
Pouwels-Fry S; Pouwels S; Fournier C; Duchemin A; Tillie-Leblond I; Le Tourneau T; Wallaert B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Dec; 25(2):133-9. PubMed ID: 19382532
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
[TBL] [Abstract][Full Text] [Related]
9. Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis.
Handa T; Nagai S; Miki S; Fushimi Y; Ohta K; Mishima M; Izumi T
Chest; 2006 May; 129(5):1246-52. PubMed ID: 16685015
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review.
Pitsiou G; Papakosta D; Bouros D
Respiration; 2011; 82(3):294-304. PubMed ID: 21677422
[TBL] [Abstract][Full Text] [Related]
11. Right and left ventricular function and pulmonary artery pressure in patients with bronchiectasis.
Alzeer AH; Al-Mobeirek AF; Al-Otair HA; Elzamzamy UA; Joherjy IA; Shaffi AS
Chest; 2008 Feb; 133(2):468-73. PubMed ID: 18071019
[TBL] [Abstract][Full Text] [Related]
12. Incidence of pulmonary hypertension and its clinical relevance in patients with interstitial pneumonias: comparison between idiopathic and collagen vascular disease associated interstitial pneumonias.
Handa T; Nagai S; Miki S; Ueda S; Yukawa N; Fushimi Y; Ito Y; Ohta K; Mimori T; Mishima M; Izumi T
Intern Med; 2007; 46(12):831-7. PubMed ID: 17575374
[TBL] [Abstract][Full Text] [Related]
13. Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis.
Song JW; Song JK; Kim DS
Respir Med; 2009 Feb; 103(2):180-6. PubMed ID: 19097877
[TBL] [Abstract][Full Text] [Related]
14. Rising stars of DPLD survival: FVC and exercise desaturation (a single-center study).
Öztürk A; Kayacan O
Turk J Med Sci; 2018 Aug; 48(4):826-832. PubMed ID: 30119159
[TBL] [Abstract][Full Text] [Related]
15. Supervised exercise training improves exercise cardiovascular function in idiopathic pulmonary fibrosis.
Vainshelboim B; Kramer MR; Fox BD; Izhakian S; Sagie A; Oliveira J
Eur J Phys Rehabil Med; 2017 Apr; 53(2):209-218. PubMed ID: 27996217
[TBL] [Abstract][Full Text] [Related]
16. CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis.
Yagi M; Taniguchi H; Kondoh Y; Ando M; Kimura T; Kataoka K; Furukawa T; Suzuki A; Johkoh T; Hasegawa Y
Respirology; 2017 Oct; 22(7):1393-1399. PubMed ID: 28488784
[TBL] [Abstract][Full Text] [Related]
17. High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.
Kim KJ; Baek IW; Park YJ; Yoon CH; Kim WU; Cho CS
Int J Rheum Dis; 2015 Jun; 18(5):524-32. PubMed ID: 24428867
[TBL] [Abstract][Full Text] [Related]
18. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension.
Mejía M; Carrillo G; Rojas-Serrano J; Estrada A; Suárez T; Alonso D; Barrientos E; Gaxiola M; Navarro C; Selman M
Chest; 2009 Jul; 136(1):10-15. PubMed ID: 19225068
[TBL] [Abstract][Full Text] [Related]
20. Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.
Hachulla E; Clerson P; Airò P; Cuomo G; Allanore Y; Caramaschi P; Rosato E; Carreira PE; Riccieri V; Sarraco M; Denton CP; Riemekasten G; Pozzi MR; Zeni S; Mihai CM; Ullman S; Distler O; Rednic S; Smith V; Walker UA; Matucci-Cerinic M; Müller-Ladner U; Launay D;
Rheumatology (Oxford); 2015 Jul; 54(7):1262-9. PubMed ID: 25596413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
